Table of Contents

    Topic review

    Protein-Energy Wasting: Acute Kidney Injury

    Subjects: Nutrition
    View times: 121
    Submitted by: Ban-Hock Khor


    Acute kidney injury is a heterogeneous group of conditions characterised by a sudden decrease in glomerular filtration rate, manifested by an increase in serum creatinine concentration or oliguria.

    Protein energy wasting is a state of decreased body stores of protein and energy fuels.

    1. Introduction

    Protein-energy wasting (PEW) was proposed by the International Society of Renal Nutrition and Metabolism (ISRNM) to define a state of decreased body stores of protein and energy fuels (body protein and fat masses) in patients with chronic kidney disease (CKD) and acute kidney injury (AKI) [1]. PEW is prevalent in AKI patients and a meta-analysis of two studies reported that the prevalence of PEW in patients with AKI was ~66.7% [2]. The pathogenesis of PEW in AKI is multifactorial, including metabolic alterations and impaired homeostasis responses due to sudden loss of kidney function [3], intrarenal and systemic inflammation associated with AKI [4], hypercatabolic state from the underlying comorbidity and critical illness [5], and amino acid loss in KRTs [6].

    2. Assessment of PEW in Patients with AKI

    Nutritional status assessment is critical to identify patients who are PEW and at risk of mortality. The ISRNM expert panel recommends that clinical diagnosis of PEW requires at least three out of four main categories, namely serum biochemistry; low body weight, reduced total body fat, or weight loss; a decrease in muscle mass; low protein or energy intakes [1]. Subjective global assessment (SGA) has also been used for assessment of PEW [2].

    a. Serum Biochemistry

    Serum albumin is frequently used to assess nutritional status, as it is relatively inexpensive and widely available, though serum pre-albumin is considered more sensitive due to its shorter half-life (2–3 days) than serum albumin (20 days) [7]. Although the synthesis of albumin and pre-albumin is influenced by dietary protein intakes​, non-nutritional factors such as inflammation, overhydration, physiological stress, and infection, which are commonly experienced by patients with AKI, are also implicated in low levels of serum albumin or pre-albumin [7]. Therefore, the serum albumin and pre-albumin levels may be reduced independent of PEW. In fact, serum albumin and pre-albumin are not included in the standardized diagnostic criteria for malnutrition proposed by the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition [8], while the Global Leadership Initiative Malnutrition suggests that serum albumin and pre-albumin may be used as a supportive proxy measure of inflammation [9].

    Serum cholesterol is a parameter of malnutrition that has been included in several nutritional screening and assessment tools. A meta-analysis demonstrated that serum cholesterol was associated with the risk of malnutrition in older adults with or without acute diseases [10]. Hypocholesterolemia is paradoxically associated with reduced risk of mortality in patients on maintenance hemodialysis [11], attributed to the cholesterol-lowering effect of systemic inflammation and malnutrition [12]. Similar to other visceral proteins, hypocholesterolemia had been documented in critically injured patients, which was correlated with organ dysfunction and presence of infections [13].

    b. Body Mass

    Evaluation of body mass and muscle mass using anthropometric measures and physical examination are important diagnostic criteria of PEW [1]. BMI is the most widely used indicator of body mass and has been shown to be paradoxically associated with mortality in CKD patients on dialysis [14]. The obesity paradox observed in patients with renal insufficiency may be explained by higher plasma levels of protective mediators, a greater hemodynamic stability during KRT, and adipose tissue acting as a “buffer” for uremic toxins [15]. Schiffl [16] reviewed eight retrospective studies, which showed conflicting findings on the association between BMI and mortality in critically ill patients with AKI, and the author suggested that the obesity paradox observed in patients with AKI could be attributed to statistical fallacy and the result of chance, bias, and residual confounding variables in retrospective cohort analyses. Essentially, PEW occurs at any BMI and unintentional weight loss should also be considered as an important indicator of PEW [1]. In the context of acute illness, unintentional weight loss of more than 1% within a week should be suggestive of PEW [8], but assessment of weight loss in patients with AKI is challenging as weight changes are often masked with fluid retention.

    c. Muscle Mass

    Muscle wasting is a fundamental feature of PEW. Objective and feasible assessment of muscle mass is essential for diagnosis of PEW. Mid-arm muscle circumference is a measured surrogate of lean body mass that has been shown to be a significant predictor of survival in patients on maintenance hemodialysis [17]. Measurement of arm circumference is not sensitive to identify muscle wasting during acute illness [18], and the accuracy and practicability of this anthropometric measurement in sedated or bed-ridden patients with edema is uncertain. Sabatino et al. [19] proposed that ultrasound imaging of quadriceps muscle is a reliable and non-invasive method for evaluation of skeletal muscle in patients with AKI, and this method had been validated against the computerized tomography scan [20]. Further studies investigating the potential utility of this muscle assessment method in patients with AKI are warranted.

    d. Dietary Intake

    Suboptimal nutritional intake is one of the contributory factors to development of PEW. The nutritional requirements of patients with AKI are affected by disease severity, pre-existing nutritional status, underlying co-morbidities, and KRT modality. The clinical practice guidelines have recommended energy and protein intakes of 20–30 kcal/kg/day and 1.2–2.0 g/kg/day for patients with AKI, respectively [21][22]. However, our systematic review showed that the means of energy and protein intake among patients with AKI were much lower than the recommended amount, which were 11.0–​13.5 kcal/kg/day and 0.50–​0.64 g/kg/day, respectively [23]​. There was inconclusive evidence on the association between energy and protein intake with clinical outcomes in patients with AKI, and those studies that reported higher mortality risk in patients with low energy and protein intakes had limitations with the statistical models that were not fully adjusted [23]​​. Meta-analyses of randomized controlled trials have demonstrated that energy and protein provisions were not associated with clinical outcomes in critically ill patients [24][25], though data specific to AKI patients was lacking. Hypocaloric nutrition is suggested at the early phase of critical illness to avoid overfeeding as substantial energy is produced endogenously via substrate mobilization [26]. In preclinical studies, energy restriction has been shown to exert renoprotective effects during AKI [27]. Although a greater amount of protein provision is recommended to achieve positive nitrogen balance, particularly in AKI patients undergoing KRTs [22], high protein intakes are potentially associated with negative metabolic complications and poorer clinical outcomes [28][29]. Future work is required to determine optimal energy and protein provision to patients with AKI.

    e. Subjective Global Assessment

    SGA is a scoring tool consisting of five components of medical history (weight change, dietary intake, gastrointestinal symptoms, functional capacity, and metabolic requirement) and three components of physical examination (loss of body fat, loss of muscle mass, and presence of edema/ascites). A SGA rating is derived based on these components, which "A" indicates well-nourished/normal, "B" indicates mildly/moderately malnourished, while "C" indicates severely malnourished [30][31]. Our systematic review observed a high prevalence of PEW (ranging from 67.9 to 82.1%) assessed via SGA in patients with AKI and the meta-analysis showed that PEW diagnosed based on SGA B or C was associated with increased risk mortality by almost twofold (Risk ratio: 1.99, 95% CI: 1.36–2.91) [23].​

    3. Conclusions

    SGA is a valid tool for assessment of PEW in patients with AKI, as it has been demonstrated to be associated with increased mortality risk. Standard nutrition parameters have been widely used for diagnosis of PEW in patients with CKD​, however these parameters in isolation have limited prognostic validity with clinical outcomes in patients with AKI, who are often presented with fluid accumulation and deranged metabolic profile​. The cut-off values of these standard nutrition parameters may not be relevant for patients with AKI experiencing drastic deterioration in nutritional status​. There is a critical need to explore other novel and validated nutrition parameters for PEW assessment in patients with AKI. Further studies are also warranted to examine whether AKI patients diagnosed with PEW will be benefited from aggressive nutrition therapy.

    The entry is from 10.3390/nu12092809


    1. Denis Fouque; Kamyar Kalantar-Zadeh; J. Kopple; N. Cano; P. Chauveau; L. Cuppari; Harold A. Franch; G. Guarnieri; T.A. Ikizler; G. Kaysen; et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney International 2008, 73, 391-398, 10.1038/
    2. Juan Jesús Carrero; Fridtjof Thomas; Kristóf Nagy; Fatiu Arogundade; Carla M. Avesani; Maria Chan; Michal Chmielewski; Antonio C. Cordeiro; Angeles Espinosa-Cuevas; Enrico Fiaccadori; et al. Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. Journal of Renal Nutrition 2018, 28, 380-392, 10.1053/j.jrn.2018.08.006.
    3. Enrico Fiaccadori; Umberto Maggiore; Aderville Cabassi; Santo Morabito; Giuseppe Castellano; Giuseppe Regolisti; Nutritional Evaluation and Management of AKI Patients. Journal of Renal Nutrition 2013, 23, 255-258, 10.1053/j.jrn.2013.01.025.
    4. Hamid Rabb; Matthew D. Griffin; Dianne B. McKay; Sundararaman Swaminathan; Peter Pickkers; Mitchell H. Rosner; John A. Kellum; C Ronco; Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps. Journal of the American Society of Nephrology 2015, 27, 371-379, 10.1681/ASN.2015030261.
    5. Marina Nogueira Berbel Bufarah; Cassiana Regina De Góes; Mariana Cassani De Oliveira; Daniela Ponce; André Luis Balbi; Estimating Catabolism: A Possible Tool for Nutritional Monitoring of Patients With Acute Kidney Injury. Journal of Renal Nutrition 2017, 27, 1-7, 10.1053/j.jrn.2016.09.002.
    6. Jayshil J. Patel; Craig J. McClain; Menaka Sarav; Jill Hamilton-Reeves; Ryan T. Hurt; Protein Requirements for Critically Ill Patients With Renal and Liver Failure. Nutrition in Clinical Practice 2017, 32, 101S-111S, 10.1177/0884533616687501.
    7. Ulrich Keller; Nutritional Laboratory Markers in Malnutrition.. Journal of Clinical Medicine 2019, 8, 775, 10.3390/jcm8060775.
    8. Jane V. White; Peggi Guenter; Gordon Jensen; Ainsley Malone; Marsha Schofield; Consensus Statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: Characteristics Recommended for the Identification and Documentation of Adult Malnutrition (Undernutrition). Journal of the Academy of Nutrition and Dietetics 2012, 112, 730-738, 10.1016/j.jand.2012.03.012.
    9. Tommy Cederholm; G.L. Jensen; M.I.T.D. Correia; M. Cristina Gonzalez; R. Fukushima; T. Higashiguchi; G. Baptista; R. Barazzoni; R. Blaauw; A. Coats; et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clinical Nutrition 2019, 38, 1-9, 10.1016/j.clnu.2018.08.002.
    10. Zhiying Zhang; Suzette L. Pereira; Menghua Luo; Eric M. Matheson; Evaluation of Blood Biomarkers Associated with Risk of Malnutrition in Older Adults: A Systematic Review and Meta-Analysis. Nutrients 2017, 9, 829, 10.3390/nu9080829.
    11. Ryan D. Kilpatrick; Charles J. McAllister; Csaba P. Kovesdy; Stephen F. Derose; Joel D. Kopple; Kamyar Kalantar-Zadeh; Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race. Journal of the American Society of Nephrology 2006, 18, 293-303, 10.1681/asn.2006070795.
    12. YongMei Liu; Josef Coresh; Joseph A. Eustace; J. Craig Longenecker; B.G. Jaar; Nancy E. Fink; Russell P. Tracy; Neil R. Powe; Michael J. Klag; Association Between Cholesterol Level and Mortality in Dialysis Patients. JAMA 2004, 291, 451-459, 10.1001/jama.291.4.451.
    13. C Michael Dunham; Michael H Fealk; Wilbur E Sever; Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Critical Care 2003, 7, R145-R153, 10.1186/cc2382.
    14. Mehran Rahimlu; Sakineh Shab-Bidar; Kurosh Djafarian; Body Mass Index and All-cause Mortality in Chronic Kidney Disease: A Dose–response Meta-analysis of Observational Studies. Journal of Renal Nutrition 2017, 27, 225-232, 10.1053/j.jrn.2017.01.016.
    15. Miet Schetz; Audrey De Jong; Adam M. Deane; Wilfried Druml; Pleun Hemelaar; Paolo Pelosi; Peter Pickkers; Annika Reintam Blaser; Jason Roberts; Yasser Sakr; et al. Obesity in the critically ill: a narrative review. Intensive Care Medicine 2019, 45, 757-769, 10.1007/s00134-019-05594-1.
    16. Helmut Schiffl; Obesity and the Survival of Critically Ill Patients with Acute Kidney Injury: A Paradox within the Paradox?. Kidney Diseases 2019, 6, 13-21, 10.1159/000502209.
    17. Nazanin Noori; Joel D. Kopple; Csaba P. Kovesdy; Usama Feroze; John J. Sim; Sameer B. Murali; Amanda Luna; Myra Gomez; Claudia Luna; Rachelle Bross; et al. Mid-Arm Muscle Circumference and Quality of Life and Survival in Maintenance Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 2010, 5, 2258-2268, 10.2215/cjn.02080310.
    18. Clare L Reid; Muscle wasting and energy balance in critical illness. Clinical Nutrition 2004, 23, 273-280, 10.1016/s0261-5614(03)00129-8.
    19. Alice Sabatino; Giuseppe Regolisti; Laura Bozzoli; Filippo Fani; Riccardo Antoniotti; Umberto Maggiore; Enrico Fiaccadori; Reliability of bedside ultrasound for measurement of quadriceps muscle thickness in critically ill patients with acute kidney injury. Clinical Nutrition 2017, 36, 1710-1715, 10.1016/j.clnu.2016.09.029.
    20. Alice Sabatino; Giuseppe Regolisti; Francesca Di Mario; Andrea Ciuni; Anselmo Palumbo; Francesco Peyronel; Umberto Maggiore; Enrico Fiaccadori; Validation by CT scan of quadriceps muscle thickness measurement by ultrasound in acute kidney injury. Journal of Nephrology 2019, 33, 109-117, 10.1007/s40620-019-00659-2.
    21. Arif Khwaja; KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron 2012, 120, 179-184, 10.1159/000339789.
    22. Stephen A. McClave; Beth E. Taylor; Robert G. Martindale; Malissa M. Warren; Debbie R. Johnson; Carol Braunschweig; Mary S. McCarthy; Evangelia Davanos; Todd W. Rice; Gail A. Cresci; et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient. Journal of Parenteral and Enteral Nutrition 2016, 40, 159-211, 10.1177/0148607115621863.
    23. Ban-Hock Khor; Hui-Ci Tiong; Shing Cheng Tan; Raha Abdul Rahman; Abdul Halim Abdul Gafor; Protein-Energy Wasting Assessment and Clinical Outcomes in Patients with Acute Kidney Injury: A Systematic Review with Meta-Analysis. Nutrients 2020, 12, 2809, 10.3390/nu12092809.
    24. Kate Fetterplace; Benjamin M. T. Gill; Lee‐Anne S. Chapple; Jeffrey J. Presneill; Christopher MacIsaac; Adam M. Deane; Systematic Review With Meta‐Analysis of Patient‐Centered Outcomes, Comparing International Guideline–Recommended Enteral Protein Delivery With Usual Care. Journal of Parenteral and Enteral Nutrition 2019, 44, 610-620, 10.1002/jpen.1725.
    25. Hasan Al-Dorzi; Abdullah A. Albarrak; Mazen Saleh Ferwana; M.H. Murad; Yaseen Arabi; Lower versus higher dose of enteral caloric intake in adult critically ill patients: a systematic review and meta-analysis. Critical Care 2016, 20, 1-19, 10.1186/s13054-016-1539-3.
    26. Pierre Singer; Annika Reintam Blaser; Mette M. Berger; Waleed Alhazzani; Philip C. Calder; Michael P. Casaer; Michael Hiesmayr; Konstantin Mayer; Juan C. Montejo; Claude Pichard; et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition 2019, 38, 48-79, 10.1016/j.clnu.2018.08.037.
    27. Si-Yang Wang; Guang-Yan Cai; Xiang-Mei Chen; Energy restriction in renal protection. British Journal of Nutrition 2018, 120, 1149-1158, 10.1017/s0007114518002684.
    28. Yaseen M. Arabi; Hasan M. Al-Dorzi; Musharaf Sadat; Protein intake and outcome in critically ill patients. Current Opinion in Clinical Nutrition & Metabolic Care 2020, 23, 51-58, 10.1097/mco.0000000000000619.
    29. Daren K. Heyland; Renee D. Stapleton; Charlene Compher; Should We Prescribe More Protein to Critically Ill Patients?. Nutrients 2018, 10, 462, 10.3390/nu10040462.
    30. Alison L. Steiber; Kamyar Kalantar-Zadeh; Donna Secker; Maureen McCarthy; Ashwini Sehgal; Linda McCann; Subjective Global Assessment in chronic kidney disease: A review. Journal of Renal Nutrition 2004, 14, 191-200, 10.1016/s1051-2276(04)00139-6.
    31. As Detsky; M. A. McLaughlin; Jp Baker; N Johnston; S Whittaker; Ra Mendelson; Kn Jeejeebhoy; What is subjective global assessment of nutritional status?. Journal of Parenteral and Enteral Nutrition 1987, 11, 8-13, 10.1177/014860718701100108.